KemPharm Statistics

Share Statistics

KemPharm has 34.5M shares outstanding. The number of shares has increased by 21.04% in one year.

Shares Outstanding	34.5M
Shares Change (YoY)	21.04%
Shares Change (QoQ)	0.24%
Owned by Institutions (%)	n/a
Shares Floating	31.26M
Failed to Deliver (FTD) Shares	675
FTD / Avg. Volume	0.29%

Short Selling Information

The latest short interest is 1.45M, so 0% of the outstanding shares have been sold short.

Short Interest	1.45M
Short % of Shares Out	n/a
Short % of Float	4.65%
Short Ratio (days to cover)	10.05

Valuation Ratios

The PE ratio is -2.55 and the forward PE ratio is null. KemPharm's PEG ratio is 0.

PE Ratio	-2.55
Forward PE	n/a
PS Ratio	11.38
Forward PS	n/a
PB Ratio	6.77
P/FCF Ratio	-3.86
PEG Ratio	0

Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for KemPharm.

EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.53, with a Debt / Equity ratio of 1.52.

Current Ratio	2.53
Quick Ratio	2.47
Debt / Equity	1.52
Debt / EBITDA	-0.69
Debt / FCF	-0.87
Interest Coverage	11.84

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

Return on Equity	n/a
Return on Assets	n/a
Return on Invested Capital	n/a
Revenue Per Employee	$983.83K
Profits Per Employee	$-4.4M
Employee Count	24
Asset Turnover	0.13
Inventory Turnover	3.76

Taxes

Income Tax	-15.37M
Effective Tax Rate	17.05%

Stock Price Statistics

The stock price has increased by 0% in the last 52 weeks. The beta is 2.16, so KemPharm's price volatility has been higher than the market average.

Beta	2.16
52-Week Price Change	n/a
50-Day Moving Average	5.22
200-Day Moving Average	5.25
Relative Strength Index (RSI)	60.63
Average Volume (20 Days)	229,541

Income Statement

In the last 12 months, KemPharm had revenue of 23.61M and earned -105.51M in profits. Earnings per share was -2.28.

Revenue	23.61M
Gross Profit	16.2M
Operating Income	-87M
Net Income	-105.51M
EBITDA	-87M
EBIT	n/a
Earnings Per Share (EPS)	-2.28

Full Income Statement

Balance Sheet

The company has 33.78M in cash and 60.3M in debt, giving a net cash position of -26.51M.

Cash & Cash Equivalents	33.78M
Total Debt	60.3M
Net Cash	-26.51M
Retained Earnings	-505.29M
Total Assets	172.71M
Working Capital	54.6M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -69.67M and capital expenditures 0, giving a free cash flow of -69.67M.

Operating Cash Flow	-69.67M
Capital Expenditures	n/a
Free Cash Flow	-69.67M
FCF Per Share	-1.51

Full Cash Flow Statement

Margins

Gross margin is 68.59%, with operating and profit margins of -368.47% and -446.85%.

Gross Margin	68.59%
Operating Margin	-368.47%
Pretax Margin	-381.76%
Profit Margin	-446.85%
EBITDA Margin	-368.47%
EBIT Margin	-368.47%
FCF Margin	-295.04%

Dividends & Yields

KMPH does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Payout Ratio	n/a
Earnings Yield	n/a
FCF Yield	n/a

Dividend Details

Analyst Forecast

Currently there are no analyst rating for KMPH.

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on Dec 28, 2020. It was a backward split with a ratio of 1:16.

Last Split Date	Dec 28, 2020
Split Type	backward
Split Ratio	1:16

Scores

Altman Z-Score	-5.53
Piotroski F-Score	2

KemPharm Inc. (KMPH)